Back to FCPM III SERVICES B.V.
Q3 2026 13F filing
Updated 6 days ago21 disclosed positions worth $1.1B
Portfolio value
$1.1B
Total holdings
21
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-16
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | ? N/A BRAVEHEART BIO INC | $235.1M | 11.64M | 22.17% | — |
| 2 | ? N/A BRAVEHEART BIO INC | $205.7M | 10.19M | 19.40% | — |
| 3 | N NEWAMSTERDAM PHARMA COMPANY | $113M | 4.65M | 10.66% | — |
| 4 | N NEWAMSTERDAM PHARMA COMPANY | $93.4M | 3.84M | 8.81% | — |
| 5 | K KORSANA BIOSCIENCES INC | $70.1M | 2.19M | 6.61% | — |
| 6 | V VOR BIOPHARMA INC | $65M | 3.41M | 6.13% | — |
| 7 | ? N/A DAMORA THERAPEUTICS INC | $51.9M | 2.44M | 4.90% | — |
| 8 | M MAPLIGHT THERAPEUTICS INC | $45.1M | 4.43M | 4.25% | — |
| 9 | D DYNE THERAPEUTICS INC | $34.8M | 2.16M | 3.28% | — |
| 10 | A AURA BIOSCIENCES INC | $33M | 5.25M | 3.11% | — |
| 11 | C CRESCENT BIOPHARMA INC. | $29.5M | 2.02M | 2.78% | — |
| 12 | D DYNE THERAPEUTICS INC | $23M | 1.43M | 2.17% | — |
| 13 | Q REPLIMUNE GROUP INC | $22.8M | 1.72M | 2.15% | — |
| 14 | E ENGENE HOLDINGS INC | $13.5M | 6.74M | 1.27% | — |
| 15 | B BICYCLE THERAPEUTICS PLC | $12.8M | 3.47M | 1.20% | — |
| 16 | E ENGENE HOLDINGS INC | $5.8M | 2.89M | 0.55% | — |
| 17 | T TARSUS PHARMACEUTICALS INC | $5M | 64.1K | 0.47% | — |
| 18 | E ENGENE HOLDINGS INC | $481K | 2.40M | 0.05% | — |
| 19 | L LISATA THERAPEUTICS INC | $225K | 156.5K | 0.02% | — |
| 20 | L LISATA THERAPEUTICS INC | $203K | 141.0K | 0.02% | — |
| 21 | E ENGENE HOLDINGS INC | $95K | 475.1K | 0.01% | — |